Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ALG12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996634 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDK11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESCO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPO6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927562 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HEXA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHAMMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSTM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SECISBP2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6872 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4656 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01000 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on